Delving into the Latest Updates on Beijing Zidu Hongye Technology Development Co Ltd with Synapse

Overview

Tags

Other Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

Opioid receptors	1

The use of buprenorphine (methadone) for detoxification or induced bridging of opioid addicts with the introduction of thiophene hydrochloride tablets for relapse prevention treatment, as well as the observation of patients' tolerance to thiophene hydrochloride tablets under the established medication regimen, provide a basis for the design of dosing regimens for this target subject population in the Phase IIa trial.

Start Date-

Sponsor / Collaborator

Academy of Military Med Sci, Inst of Toxicology & Pharmacology

[+1]

CTR20150565

/ Not yet recruitingPhase 2

盐酸噻吩诺啡片预防阿片类依赖者脱毒后复吸有效性与安全性的多中心、双盲、随机对照II期临床研究

[Translation] A multicenter, double-blind, randomized controlled phase II clinical study on the efficacy and safety of thiophene hydrochloride tablets in preventing relapse in opioid addicts after detoxification

通过评价盐酸噻吩诺啡片在阿片类依赖者脱毒后预防复吸的有效性与安全性，为后续试验给药方案确定提供科学依据.

[Translation]

The effectiveness and safety of thiophene hydrochloride tablets in preventing relapse in opioid addicts after detoxification were evaluated to provide a scientific basis for determining the dosing regimen in subsequent trials.

Start Date-

Sponsor / Collaborator

Academy of Military Med Sci, Inst of Toxicology & Pharmacology

[+1]

NCT03656120

/ Unknown statusPhase 2IIT

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase Ⅱb Clinical Trial of Thienorphine Hydrochloride Tablets for the Efficacy, Safety, and Optimal Dosing of Relapse Prevention After Opioid Dependence Detoxification

Opioid addiction is common worldwide. Thienorphine hydrochloride is a newly partial opioid receptor agonist drugs. It's affinity with opioid receptors was much higher than opioids, which could effectively prevents opioid dependence by stop opioids competition for opioid receptors and causing opioid dependence. The aim of this research was to determine whether thienorphine hydrochloride would reduce opioid use and better preventing relapse among opioid addicts.

Start Date31 Aug 2018

Sponsor / Collaborator

Central South University

[+4]

100 Clinical Results associated with Beijing Zidu Hongye Technology Development Co Ltd

Login to view more data

0 Patents (Medical) associated with Beijing Zidu Hongye Technology Development Co Ltd

Login to view more data

100 Deals associated with Beijing Zidu Hongye Technology Development Co Ltd

Login to view more data

100 Translational Medicine associated with Beijing Zidu Hongye Technology Development Co Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data